Mark R. Hake

Mark R. Hake

Mark R. Hake, CFA is a financial analyst and entrepreneur. He has been a Chartered Financial Analyst (CFA) for 31 years and has owned his own investment management and investment research firms that focused on value stocks, both in the U.S. and overseas.

Mark writes over 600 articles per year on stocks, cryptos, SPACs, convertibles, ETFs, and other financial securities. He has been ranked with 5 stars by TipRanks.com (under “Mark R. Hake”) with an average return of over 22% annually and #36 out of 8,116 writers. Presently he authors articles on Medium.com and other sites.

Mark also invests in public and private equities and has acted as a hedge fund manager and portfolio manager for various money management firms. He has also acted as CFO and Chief Strategy Officer for several fin-tech and software companies.

You can follow Mark on LinkedIn and on TipRanks.

Recent Articles

Alibaba Is a Great Bargain Now With Growing Earnings and Cash Flow

Alibaba is a great bargain now with growing earnings and cash flow. BABA stock trades well below Amazon but has similar growth and better margins.

Ford Stock Could Move a Good Deal Higher as Earnings Estimates Climb

Ford stock could move a good deal higher as earnings estimates climb. Ford stock could rise another 50% based on probability estimates of a restored dividend and its plans for electric vehicles.

Ideanomics Is Plowing Through Cash with Little-to-No Upside

Ideanomics keeps losing money with a business model that has little upside. IDEX stock has little upside as the company has no chance of producing a profit anytime soon with its current business model.

Tilray Could Rise Another 50% Once It Reaches Profits By Q4

Tilray stock may keep rising with higher cannabis sales and the prospect of profits. Tilray could rise at least another 50% if it becomes profitable on an adjusted EBITDA basis in Q4.

Here’s Why Down Means Up for Starbucks

Here is how to read the Starbucks results: down means up for Starbucks stock. It is worth up to 35% more as Covid-19 restrictions ease.